€95.6 Million
EUR as of Jan. 1, 2025
US$99.5 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Limes Schlosskliniken AG has the following listings and related stock indices.
Stock: XETR: LIK wb_incandescent
Stock: FSX: LIK wb_incandescent